15% of the couples are globally affected by infertility, with male-factor accounting for 50% of the global infertility.
Diagnoses male-factor infertility to assist the clinician direct to the suitable IVF treatment.
Conventional diagnostics fail to determine fertilization capacity of sperms, thus the majority of treatments are directed to ICSI – a highly invasive method, instead of the safer and more natural standard-IVF.
DECREASE IN SPERM COUNT SINCE 1970S
UNEXPLAINED MALE INFERTILITY
IVF CYCLES PERFORMED ANNUALLY
A patented, user friendly, rapid and small footprint Diagnostic System which predicts the fertilization capacity of sperms. This will assist the clinicians and embryologists to decide if the suitable treatment is standard-IVF or ICSI.
Millions of couples waiting in queue for 1-3 years for IVF can now be helped quicker and more economically.
Breakthrough Platform technology
This will lead to an immediate decision if the sperm sample is suitable for standard-IVF or ICSI, thus drastically limiting the number of cycles required for fertilisation and reducing the burden of infertility on the female partner.
Get the latest news by signing up to our monthly newsletter. We welcome you to contact us with any thoughts you may have.